Sanofi - Q3 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Nasdaq hits record high after softer jobs data tempers rate-hike bets
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- Twilio, Vylor set to join S&P 500 as index reshuffles members
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
Sanofi (SNY) Reports Q3 EPS of EUR1.25
October 29, 2015 6:18 AM EDTSanofi (NYSE: SNY) reported Q3 EPS of EUR1.25, versus EUR0.91 reported last year. Revenue for the quarter came in at EUR9.59 million, versus EUR8.78 million reported last year.
Broad-based sales growth despite Diabetes sales erosion in the U.S.
